Key Takeaways
Soy's effectiveness for menopause varies dramatically between women, but research shows measurable benefits for those who incorporate it consistently into their diet.
• Soy reduces hot flashes by 20-26% compared to placebo, but requires 13+ weeks of consistent use to see maximum benefits
• Only 30-50% of people can produce equol (the active compound), explaining why soy works better for some women than others
• Aim for 40-80mg of isoflavones daily through whole foods like tofu, tempeh, and soy milk rather than supplements
• Safety fears about breast cancer and thyroid issues are largely unfounded for most women with adequate iodine intake
• Fermented soy products like tempeh and miso offer better absorption than non-fermented options like plain tofu
The key to success with soy for menopause lies in patience and consistency. Unlike hormone therapy that works within weeks, soy's phytoestrogens need months to build up in your system. Whether you're an equol producer or not, incorporating 2-3 servings of whole soy foods daily provides a safe, natural approach to managing menopausal symptoms while supporting bone and heart health.
Hot flashes affect about 70-80% of women during menopause, which prompts many to seek natural relief through soy for menopause. But research shows that only 10-20% of Far Eastern Asian women report experiencing these symptoms. This difference is attributed often to dietary phytoestrogens. Studies suggest that phytoestrogens can reduce hot flush frequency compared to placebo, yet results vary by a lot between individuals. This piece gets into the scientific evidence on soy isoflavones menopause benefits and explores why phytoestrogens menopause effects differ among women. We also provide practical guidance on incorporating soy into your diet.
What Are Phytoestrogens and How Do They Work?
Plant estrogens explained
Phytoestrogens represent a group of naturally derived non-steroidal plant compounds [1]. These molecules share a structural resemblance to endogenous estrogens through multiple hydroxyl-substituted aromatic rings. This allows them to interact with estrogen receptors throughout the body. The key structural elements include a phenolic ring essential for receptor binding and low molecular weight as with estrogens. Hydroxyl groups positioned at optimal distances mirror those in estradiol [2].
Four major categories of phytoestrogens exist, each with distinct food sources:
-
Isoflavones: Found in leguminous plants such as soybeans, chickpeas and red clover [1]
-
Lignans: Abundant in flaxseeds, sesame seeds, whole grains and certain vegetables [1]
-
Coumestans: Rich in sprouted plants [1]
-
Resveratrol-like compounds: We derived these from grapes and peanuts [1]
Women learning about natural remedies for menopause often turn to phytoestrogens as HRT alternatives, especially isoflavones from soy products. The Western daily intake remains low at 0.1-1.2 mg per day [3]. Asian countries consume amounts up to 47 mg per day, which is higher by a lot [3]. This dietary pattern forms part of what makes the Asian diet menopause experience different.
Soy isoflavones: genistein and daidzein
The three isoflavones in soybeans are the β-glucosides genistin, daidzin and glycitin, along with their respective aglycones: genistein, daidzein and glycitein [4]. Genistein, daidzein and glycitein comprise approximately 50%, 40% and 10% of total isoflavone content respectively. Considerable variation exists among soybean varieties [4]. Isoflavones occur almost entirely as glycosides in soybeans and unfermented soy foods [4].
These glycosides are enzymatically cleaved in the gut to their active aglycone forms when consumed [5]. The metabolism of phytoestrogens varies from person to person. Women appear to metabolize them more efficiently than men [5]. This conversion process becomes relevant when you think over soy for menopause as part of a strategic dietary approach.
How phytoestrogens interact with estrogen receptors
Phytoestrogens competitively bind to estrogen receptors ERα and ERβ against endogenous estrogens [1]. Many exhibit higher affinity for ERβ. Genistein shows 7- to 48-fold more selectivity for ERβ than ERα [6]. The relative estrogenic potency of genistein for ERβ is approximately 30-fold higher than for ERα [6]. This ERβ selectivity contributes to tissue-specific actions throughout the body.
The distribution of these receptors determines the effects of soy isoflavones menopause supplementation. ERα drives proliferative effects, whereas ERβ acts as a negative regulator and counteracts mitogenic effects [3]. Phytoestrogens bring out estrogenic-like actions in ERβ-enriched tissues such as bone and vasculature. They modulate ERα-mediated proliferative signaling in organs including the breast [1]. This selective targeting supports both menopause and bone health and menopause and cardiovascular health without stimulating breast tissue growth.
Phytoestrogens can arbitrate rapid non-genomic effects through the membrane-bound G protein-coupled estrogen receptor (GPER), distinct from classical nuclear receptor pathways [1]. GPER activation brings out rapid signaling within seconds to minutes, unlike slower genomic pathways of nuclear ERs. This drives transient cellular responses such as ion flux changes or kinase activation [1].
Estrogenic and anti-estrogenic effects
Phytoestrogens function as selective estrogen receptor modulators (SERMs) and exhibit both agonistic and antagonistic effects depending on ER subtype and tissue context [3]. Their activity resembles pharmaceutical SERMs like tamoxifen, which acts as an ER agonist in the uterus and bone but an antagonist in the breast [6].
The effects depend heavily on endogenous estrogen levels. Phytoestrogens menopause compounds compete with more potent endogenous estrogens for receptor binding in women of reproductive age with high circulating estrogen. This produces anti-estrogenic effects [3]. The same compounds exhibit weak estrogenic activity during menopause when endogenous estrogen levels drop [3]. This adaptive mechanism explains why phytoestrogens can address hot flushes without increasing risks associated with stronger estrogens.
Women thinking over menopause treatment options beyond HRT menopause therapy should understand this dual nature. The tissue-selective properties mean phytoestrogens can reduce breast cancer and menopause concerns while still providing symptom relief. Some phytoestrogens boost estrogenic signaling by upregulating estrogen receptor expression in cellular and animal models [1]. This creates a self-reinforcing beneficial effect in target tissues. Those learning about menopause supplements or managing weight gain during menopause will find that understanding these mechanisms helps explain why soy isoflavones produce variable but often positive results.
The Scientific Evidence: Do Phytoestrogens Help Menopause Symptoms?
Hot flush reduction in clinical studies
Clinical trials that examine soy for menopause symptoms reveal modest but measurable benefits. A meta-analysis of 13 trials found soy isoflavones reduced hot flash frequency by 20.6% compared with placebo [7]. The actual reduction reached 25.2% when accounting for placebo effects and represented 57% of estradiol's maximum effectiveness [4]. Severity decreased by 26.2% in women taking isoflavone supplements [7].
The timeline for relief is markedly different from hormone therapy. Soy isoflavones menopause supplementation requires 13.4 weeks to achieve half of maximum effects, much longer than estradiol's 3.09 weeks [4]. Treatment intervals shorter than 12 weeks prove inadequate for evaluating efficacy, and 48 weeks are needed to reach 80% of maximum benefits [4].
Genistein content influences outcomes. Supplements providing more than 18.8 mg of genistein proved twice as potent at reducing hot flushes compared with lower genistein formulations [7]. A randomized trial showed that 50 mg daily isoflavone intake reduced both attack frequency and severity over 12 weeks [4].
Placebo effects complicate interpretation. Trials observed placebo reductions reaching 35.8% for soy isoflavones and 55.6% for estradiol [4]. Red clover extracts showed faster reduction rates at first but ended up producing similar outcomes to placebo at 12 weeks [1].
Effects on bone density
Research on menopause and bone health benefits presents mixed findings. A systematic review of 23 trials with 3,494 participants concluded that phytoestrogens menopause supplementation probably prevents BMD reduction during menopause [1]. Interventions ranged from 7 weeks to 3 years and examined genistein extracts, dietary phytoestrogens, and red clover formulations [1].
Specific findings show promise. A 6-month administration of red clover extract (57-85.5 mg/day) increased BMD in the radius and ulna [3]. Another trial found that 41 mg isoflavone tablets ameliorated BMC and BMD decreases in the lumbar spine while elevating bone formation markers [3].
Evidence remains inconsistent despite positive trends. Randomized controlled trials measuring bone turnover markers revealed that soy isoflavone supplements moderately decreased bone resorption without affecting bone formation markers much [2]. Lambert's meta-analysis of 26 trials indicated moderate attenuation of bone resorption at lumbar spine and femoral neck levels [1].
Cardiovascular benefits
Soy isoflavones demonstrate measurable effects on menopause and cardiovascular health. Supplementation with soy protein isolate produced substantial reductions in calculated 10-year risk: 27% for coronary heart disease, 37% for myocardial infarction, 24% for overall cardiovascular risk, and 42% for cardiovascular death [8].
Isoflavones improve cardiovascular health through several mechanisms. They maintain endothelial integrity, increase nitric oxide and prostacyclin release, and promote endothelium-dependent vasodilation [8]. They inhibit vascular smooth muscle proliferation through cAMP- and cGMP-dependent pathways while reducing oxidative stress and vascular inflammation [8].
Vaginal health and other symptoms
Evidence for vaginal atrophy relief remains inconclusive. A meta-analysis of seven clinical trials with 494 participants found that soy increased the vaginal cell maturation index by 0.072%, though this change lacked statistical significance [9]. Studies using 47-200 mg daily for 4-53 weeks showed strong heterogeneity [9].
Meta-regression identified study duration and dose as factors creating variability. Isoflavone effectiveness decreased substantially as intervention duration extended beyond 12 weeks [9]. A systematic review of 33 studies with 2,972 individuals concluded that various phytoestrogens improved urogenital atrophy indicators and sexual function [5].
Why study results vary
Study inconsistency stems from multiple factors. Individual differences in isoflavone metabolism create substantial variability, particularly equol production capacity [4]. Only 30-50% of populations harbor intestinal bacteria capable of converting daidzein into equol [2]. Women above median BMI showed enhanced benefits, with Promensil reducing hot flashes by 49% versus 30% in thinner women [1].
Study design variations contribute to conflicting outcomes. Differences in participant characteristics, intervention duration, isoflavone product types, and dosages ranging from 30-200 mg daily create comparison difficulties [4]. Menopause treatment trials enrolling women across wide age ranges with varying symptom severity produce heterogeneous results [9].
The Equol Factor: Why Soy Works Differently for Different Women
What is equol and why does it matter?
Responses to soy for menopause vary dramatically from person to person. The equol factor explains much of this variation. Gut bacteria convert daidzein into equol, a more potent metabolite. This molecule has a chemical structure remarkably like endogenous estradiol. It can bind estrogen receptors and exert weak estrogenic effects [1].
The biological superiority of equol becomes apparent when you explore its properties. Equol demonstrates more stability, easier absorption, and lower clearance rates than daidzein, its precursor [7]. It shows stronger estrogenic activity than any other isoflavone or isoflavone-derived metabolite [7]. Equol exhibits the highest affinity for estrogen receptors among all metabolites. It binds ERβ with strong affinity [1][4]. S-equol displays 16-fold selectivity for ERβ over ERα. R-equol preferentially binds ERα [4].
Equol demonstrates anti-androgenic activity beyond estrogenic effects. It binds to and sequesters 5α-dihydrotestosterone [7]. This dual mechanism suggests benefits that extend beyond typical phytoestrogens menopause applications. Equol possesses the strongest antioxidant activity of any isoflavone-derived compound [7]. This provides protection against oxidative stress implicated in chronic diseases.
But a fundamental limitation exists. Only 30-50% of the global population can metabolize soy isoflavones into equol. Variation in gut microbiota is the main reason [1]. These people are termed equol producers, while those unable to produce equol are equol non-producers [1].
Gut bacteria and equol production
The conversion of daidzein to equol requires specific intestinal bacteria. These bacteria reside in the distal small intestine and colon [7]. Bacterial daidzein conversion produces only S-equol, despite equol being optically active with both R and S enantiomers possible [7].
Research has identified several bacterial species capable of equol production. Key organisms include Eggerthella species and Eubacterium species. Other specialized gut bacteria metabolize the intermediate product dihydrodaidzein into equol [7]. Some bacteria can produce equol independently. Others work in consortium through cross-feeding relationships [10].
Dietary patterns influence equol production capacity. The proportion of equol producers is higher among vegetarians compared to non-producers [1]. Research confirms that vegetarians were 4.25 times more likely to be equol producers than non-vegetarians. Rates were 59% versus 25% respectively [11][10]. Diets high in carbohydrates and low in saturated fat associate with equol production [11]. Fermentable fiber supplies short-chain fatty acids that modify colonic pH. This creates favorable conditions for equol-producing bacteria [10].
Higher alcohol consumption associated positively with strong equol producer phenotypes both in vivo and in vitro [1]. Antibiotic use devastates equol production. Studies found that children consuming soy-based foods experienced decreased urinary equol levels after oral antibiotic administration [1]. But research demonstrates that transplanting gut microbiota from equol producers into non-producers can enable equol production [1][7].
Asian populations and lifelong soy consumption
Population differences in equol production rates prove striking. Approximately 30% of Western populations produce equol compared to 60% of Asian populations [1]. Studies confirm that 50-70% of East Asian residents are equol producers. This contrasts sharply with 20-30% in Western countries [3][10]. Microbiome composition rather than genetics causes this difference [3].
Daily isoflavone intake patterns explain much of this disparity. Finland and the UK consume only 0.8 mg and 7-9 mg daily. China averages 97 mg and Japan 39.5 mg [1]. Asian populations consuming 25-50 mg of isoflavones daily develop gut microbiota compositions that favor equol production [12].
Continuous soy consumption may promote specific equol-converting microbial inhabitants to adapt and grow. This could potentially induce non-producers into producers [8]. Healthy eating patterns cause high microbial diversity. This may improve the quality of equol-producing bacteria [3]. This mechanism helps explain why traditional Asian diet menopause experiences differ from Western patterns.
Equol producers demonstrate lower risks of hormone-dependent diseases compared to non-producers [1]. Research found that equol-producers had lower arterial calcification scores. This suggests cardiovascular risk improvement [3].
Testing if you're an equol producer
You need to consume soy foods or daidzein supplements followed by sample collection to determine equol producer status. Based on the percentage of daidzein excreted as equol in 24-hour urine, participants can be classified as poor (61%), moderate (21%), and strong (18%) equol producers [1].
A standardized approach uses the log10-transformed urinary equol:daidzein ratio after a 3-day soy challenge. Researchers can classify people reliably using a cutoff of log(equol/daidzein) ≥ -1.42 or ≥ -1.75 [13][8]. Common protocols involve consuming 200-250 mL of soy milk twice daily for three consecutive days [14].
Equol-producing status appears stable over years [3], though it can change with dietary modifications. Women who regularly consumed soy foods had 27% higher odds of being equol producers compared to non-consumers [8]. Equol production determines much of soy isoflavones menopause efficacy. Understanding your producer status becomes relevant if you're thinking over natural remedies for menopause or HRT alternatives.
Best Soy Food Sources and How Much You Need
Selecting appropriate soy foods for a diet for menopause requires understanding isoflavone content in different products. Whole soy and traditional foods provide varying amounts of these compounds. Those learning about natural remedies for menopause need to make informed choices.
Tofu and tempeh
Tofu delivers 19.2 mg of isoflavones per 3-ounce serving [9] and 8 grams of protein [5]. Soft tofu provides about 20 mg of isoflavones [5]. This makes it a concentrated source among soy products. To name just one example, 100g of tofu contains 17g protein and 58mg isoflavones [2].
Tempeh surpasses tofu in nutritional density. Raw tempeh contains 51.5 mg of isoflavones per 3-ounce serving [9]. Cooking reduces this to 30.3 mg [9]. A 100g serving provides 21g protein and 75mg isoflavones [2]. The fermentation process breaks down sugar and protein molecules partially and may improve digestibility [5].
Edamame and soy milk
Edamame offers 16.1 mg of isoflavones per half-cup serving [9]. 100g contains 14g protein and 49mg isoflavones [2]. Boiled mature soybeans provide much more at 56 mg per half-cup [9].
Soy milk contains 6.2 mg of isoflavones per cup [9]. Values range from 0.7 to 11 mg based on how it's processed [15]. A 200ml serving delivers 6g protein and 22mg isoflavones [2]. This is a practical option for those who want to try HRT alternatives.
Miso and soy yogurt
Miso paste contains 57 mg of isoflavones per half-cup serving [5]. You should take it in small amounts because of high sodium content [16]. Soy yogurt provides 21.3 mg per half-cup [9]. 200g delivers 6.5g protein and 23mg isoflavones [2].
Recommended daily intake: 40-80mg isoflavones
Therapeutic dosages for hot flushes range from 40-70 mg daily [5]. Research suggests taking 40-80 mg of isoflavones daily [17]. You can get this from 2-3 servings of soy foods. Asian populations average 25-50 mg daily [9]. This supports benefits for menopause and bone health and menopause and cardiovascular health.
Fermented vs non-fermented soy foods
Fermentation converts glycoside isoflavones into aglycone forms. Bioavailability increases from 2-3% to 40-100% [18]. Fermented products like tempeh and miso contain compounds that absorb more readily [18]. Both fermented and non-fermented foods provide benefits for menopause treatment.
Soy supplements vs whole food sources
Whole food sources prove superior to menopause supplements. Foods provide protein, fiber, vitamins and minerals with isoflavones [5]. Supplements lack standardization. 50% contain isoflavone amounts that differ by more than 10% from label claims [9]. Soy protein isolate and isoflavone supplements are not recommended, especially when women have breast cancer history [16].
Safety Concerns: Separating Fact from Fiction
Breast cancer: what the evidence really shows
Concerns about breast cancer and menopause risk from soy isoflavones menopause supplementation lack scientific support. A 2024 study found that soy isoflavones reduced breast cancer recurrence risk in post-menopausal women and those with hormone receptor-positive cancer [19]. Women consuming the highest amounts of soy had a 59% lower risk of pre-menopausal breast cancer [19]. Multiple research studies suggest soy consumption may even lower breast cancer risk [4]. The American Cancer Society, American Institute for Cancer Research, and Canadian Cancer Society all affirm that women with breast cancer can consume soy safely [20][21]. Isoflavones compete with more potent natural estrogens for receptor binding and reduce overall estrogenic stimulation [21]. Women learning natural remedies for menopause or HRT alternatives can include soy foods as part of their diet for menopause.
Thyroid function and iodine status
Soy's effects on thyroid function depend heavily on iodine status. Soy foods or isoflavones cause little to no adverse thyroid effects in euthyroid, iodine-replete people [22]. But people with subclinical hypothyroidism showed a threefold increase in risk of developing overt hypothyroidism following 16 mg daily soy phytoestrogen supplementation [23]. A systematic review found soy modestly raises TSH levels, though this may not be clinically significant [1]. Hypothyroid patients taking levothyroxine should separate soy consumption from medication by three to four hours, as soy may interfere with thyroid hormone absorption [22][7]. Those with adequate iodine intake face minimal thyroid risks from moderate soy consumption [22].
Feminization myths debunked
Claims that soy feminizes men persist despite definitive evidence to the contrary. An expanded meta-analysis of 41 clinical studies with 1,753 men concluded that neither soy protein nor isoflavone exposure affects testosterone, free testosterone, or estrogen levels in men [24]. Two case reports describing feminizing effects involved men consuming nine times more isoflavones than typical Japanese intake [25]. Most people don't drink three quarts of soy milk daily, the amount consumed in one unusual case [26]. Breast growth occurs occasionally in men from various causes unrelated to soy [26]. Those learning menopause treatment options like red clover menopause supplements can recommend soy to male family members without concern.
Who should be cautious with soy
Some people require caution with phytoestrogens menopause supplementation. Less than 1% of the population has soy allergies [7][21]. Those with subclinical or overt hypothyroidism should monitor thyroid function if they keep taking soy, especially during pregnancy [1]. People taking monoamine oxidase inhibitors should avoid soy products high in tyramine like tofu and soy sauce due to potential blood pressure interactions [27]. Soy use during pregnancy in amounts exceeding those commonly found in foods may be unsafe [27]. Women on thyroid hormone replacement should discuss soy intake with healthcare providers [7]. Those managing hot flushes or weight gain during menopause through HRT menopause therapy can safely incorporate moderate soy consumption. Soy supplements containing concentrated isoflavones are not recommended, especially if you have breast cancer history [20][13]. Whole soy foods remain the preferred choice over menopause supplements.
Making Soy Part of Your UK Diet
UK availability and cost considerations
Major UK supermarkets stock detailed soy ranges. Tesco offers soy milk from £0.79 to £1.30 [10], while Morrisons and Asda provide comparable options at £1.24-£1.78 [10]. Premium brands like Bonsoy reach £3.20 [10]. Soy sauce costs £0.55-£3.00 at Tesco and Morrisons [28]. Most chains carry tofu, tempeh and edamame in refrigerated and frozen sections. This makes soy for menopause both available and affordable.
Simple ways to add soy to meals
Replace half the ground beef in spaghetti sauce, chili or meatloaf with textured vegetable protein [3]. Cube firm tofu for stir-fries or fajitas instead of chicken [3]. Use soy milk on cereal or in coffee as a direct cow's milk substitute [12]. Steam edamame and add to salads [12]. Blend silken tofu with sour cream for vegetable dips [3]. These swaps support natural remedies for menopause through dietary modification.
Reading labels for isoflavone content
UK labels display isoflavone content rarely. Focus on minimally processed options like whole soybeans, tofu, tempeh and plain soy milk rather than heavily processed products [3][29]. Supplements cannot guarantee actual isoflavone amounts [3]. This reinforces why whole foods prove superior to menopause supplements.
Conclusion
Soy won't work the same way to everyone during menopause, but evidence supports its modest benefits. Hot flush reduction, bone health and cardiovascular protection are the main areas where it helps. Equol production capacity explains much of this variation. Both producers and non-producers can experience relief through consistent consumption of 40-80mg isoflavones daily.
Whole soy foods like tofu and tempeh offer complete nutritional value and are better than concentrated supplements. Most women don't need to worry about safety concerns regarding breast cancer and thyroid function. These have been debunked. Women who seek natural remedies beyond HRT alternatives should try incorporating two to three servings of soy foods daily. This represents an evidence-based approach that's practical.
FAQs
Q1. Can soy isoflavones actually reduce hot flashes during menopause? Yes, research shows that soy isoflavones can reduce hot flash frequency by approximately 20-26% compared to placebo. However, the effects are modest and take time to develop—typically requiring 12-13 weeks before noticeable improvement occurs. Women consuming 40-80mg of isoflavones daily (equivalent to 2-3 servings of soy foods) tend to experience the best results, though individual responses vary significantly.
Q2. Are phytoestrogens from soy safe for women with breast cancer concerns? Current evidence indicates that soy consumption is safe and may even be protective. Studies show that women consuming the highest amounts of soy have up to 59% lower risk of pre-menopausal breast cancer, and soy isoflavones may reduce breast cancer recurrence in post-menopausal women. Major cancer organizations including the American Cancer Society confirm that soy can be safely consumed by women with breast cancer history, as phytoestrogens compete with stronger natural estrogens for receptor binding.
Q3. Why do soy isoflavones work better for some women than others? The key factor is equol production—only 30-50% of people can convert soy isoflavones into equol, a more potent compound with stronger estrogenic effects. This ability depends on specific gut bacteria that vary between individuals. Asian populations show higher equol production rates (50-70%) compared to Western populations (20-30%), largely due to lifelong soy consumption patterns that promote beneficial gut bacteria. Vegetarians are also 4.25 times more likely to be equol producers.
Q4. What are the best soy food sources for managing menopause symptoms? Whole soy foods are superior to supplements. Tempeh provides the highest isoflavone content (30-51mg per 3-ounce serving), followed by tofu (19-20mg per 3 ounces), edamame (16mg per half-cup), and soy milk (6mg per cup). Fermented soy products like tempeh and miso offer better absorption due to their aglycone form. Aim for 40-80mg of isoflavones daily through 2-3 servings of varied soy foods rather than concentrated supplements.
Q5. Does soy consumption affect thyroid function or hormone levels? In people with adequate iodine intake and normal thyroid function, soy foods cause little to no adverse thyroid effects. However, those with subclinical hypothyroidism or taking thyroid medication should exercise caution and separate soy consumption from medication by 3-4 hours. The myth that soy feminizes men has been thoroughly debunked—a meta-analysis of 41 studies involving 1,753 men found no effect on testosterone or estrogen levels from normal soy consumption.
References
[1] - https://www.nature.com/articles/s41598-019-40647-x
[2] - https://www.clairepettitt.com/blog/all-you-need-to-know-about-endometriosis-and-soy
[3] - https://nutrition.ucdavis.edu/outreach/nutr-health-info-sheets/pro-soy
[4] - https://bastyr.edu/about/news/debunking-three-myths-about-soy
[5] - https://nutritionsource.hsph.harvard.edu/soy/
[6] - https://pmc.ncbi.nlm.nih.gov/articles/PMC3074428/
[7] - https://www.palomahealth.com/learn/soy-hypothyroidism?srsltid=AfmBOooE8lgq1UMx0CpdiZSHDNHuXDRvYHZFiWBVhCIUJIXP0FwU9aEB
[8] - https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201318
[9] - https://lpi.oregonstate.edu/mic/dietary-factors/phytochemicals/soy-isoflavones
[10] - https://www.trolley.co.uk/explore/soya-drinks
[11] - https://www.sciencedirect.com/science/article/pii/S0022316622084140
[12] - https://www.health.harvard.edu/staying-healthy/add-soy-to-your-diet-but-dont-subtract-other-healthy-foods
[13] - https://www.mdanderson.org/cancerwise/is-soy-safe-for-patients-with-breast-cancer.h00-159538167.html
[14] - https://www.benchchem.com/pdf/Application_Notes_and_Protocols_for_Determining_Equol_Producer_Status_in_Study_Participants.pdf
[15] - https://www.bbc.com/future/article/20190816-is-soy-bad-for-womens-health
[16] - https://www.cancer.org.au/about-us/policy-and-advocacy/prevention/obesity/related-resources/information-sheet-soy-isoflavones
[17] - https://www.ebsco.com/research-starters/complementary-and-alternative-medicine/isoflavones-therapeutic-uses
[18] - https://pmc.ncbi.nlm.nih.gov/articles/PMC9416513/
[19] - https://www.breastcancer.org/managing-life/diet-nutrition/breast-cancer-risk-reduction/foods/soy
[20] - https://www.cancer.org/cancer/latest-news/soy-and-cancer-risk-our-experts-advice.html
[21] - https://www.eufic.org/en/healthy-living/article/is-soy-good-or-bad-for-you-heres-what-the-science-says
[22] - https://pubmed.ncbi.nlm.nih.gov/16571087/
[23] - https://cot.food.gov.uk/sites/default/files/TOX2014-41_0.pdf
[24] - https://pubmed.ncbi.nlm.nih.gov/33383165/
[25] - https://sniglobal.org/origins-of-the-soy-feminization-myth/
[26] - https://www.washingtonpost.com/wellness/2024/04/20/soy-milk-men-breasts-myth/
[27] - https://www.nccih.nih.gov/health/soy
[28] - https://www.tesco.com/groceries/en-GB/shop/food-cupboard/cooking-sauces-meal-kits-and-sides/chinese/soy-sauce?srsltid=AfmBOoqmxXdZ1APom4XrP6Z8IC-aVzxWFUUD8vovx4TaZqnDWtXo39JE
[29] - https://patient.uwhealth.org/healthfacts/344
